News
Some experts say oral versions of popular weight-loss drugs such as Wegovy could offer people more flexibility and ...
Eli Lilly and Novo Nordisk dominate the billion-dollar weight loss drug market. Lilly has announced positive trial results ...
A unique Novo Nordisk legal challenge to the Medicare drug pricing program could have big implications for the pharma ...
Drugmaker Eli Lilly (NYSE: LLY) hasn't been exempt from the recent market pullback, but its stock shot higher following the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results